Susanne Grafe

1.5k total citations
18 papers, 1.1k citations indexed

About

Susanne Grafe is a scholar working on Neurology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Susanne Grafe has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Neurology, 9 papers in Cellular and Molecular Neuroscience and 1 paper in Oncology. Recurrent topics in Susanne Grafe's work include Neurological disorders and treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (16 papers) and Hereditary Neurological Disorders (7 papers). Susanne Grafe is often cited by papers focused on Neurological disorders and treatments (16 papers), Botulinum Toxin and Related Neurological Disorders (16 papers) and Hereditary Neurological Disorders (7 papers). Susanne Grafe collaborates with scholars based in Germany, United States and Czechia. Susanne Grafe's co-authors include Georg Comes, Joseph Jankovic, Wolfgang H. Jost, Petr Kaňovský, Angelika Hanschmann, Cynthia Comella, Evžen Růžička, R. Benecke, Katalin Bihari and P. Roggenkämper and has published in prestigious journals such as Neurology, Journal of Hepatology and Movement Disorders.

In The Last Decade

Susanne Grafe

15 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susanne Grafe Germany 12 1.1k 463 207 130 98 18 1.1k
Benjamin Zakine France 9 522 0.5× 145 0.3× 102 0.5× 52 0.4× 163 1.7× 10 587
Fereshte Adib Saberi Germany 13 655 0.6× 235 0.5× 189 0.9× 45 0.3× 45 0.5× 28 786
Angelika Hanschmann Germany 12 476 0.5× 197 0.4× 114 0.6× 44 0.3× 77 0.8× 35 565
Ivana Basta Serbia 19 843 0.8× 565 1.2× 74 0.4× 35 0.3× 16 0.2× 100 1.1k
A. Richardson United Kingdom 5 315 0.3× 115 0.2× 68 0.3× 30 0.2× 22 0.2× 5 381
Sara Samadzadeh Germany 13 158 0.1× 75 0.2× 25 0.1× 61 0.5× 15 0.2× 61 357
N. Heye Germany 14 305 0.3× 90 0.2× 39 0.2× 41 0.3× 36 0.4× 33 619
A Joffroy Belgium 12 154 0.1× 64 0.1× 116 0.6× 82 0.6× 5 0.1× 19 355
Christoph Schmitz Germany 6 200 0.2× 85 0.2× 222 1.1× 8 0.1× 8 0.1× 10 438
Madlen Loebel Germany 8 162 0.2× 66 0.1× 42 0.2× 47 0.4× 45 0.5× 11 514

Countries citing papers authored by Susanne Grafe

Since Specialization
Citations

This map shows the geographic impact of Susanne Grafe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susanne Grafe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susanne Grafe more than expected).

Fields of papers citing papers by Susanne Grafe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susanne Grafe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susanne Grafe. The network helps show where Susanne Grafe may publish in the future.

Co-authorship network of co-authors of Susanne Grafe

This figure shows the co-authorship network connecting the top 25 collaborators of Susanne Grafe. A scholar is included among the top collaborators of Susanne Grafe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susanne Grafe. Susanne Grafe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bertram, Eva, et al.. (2015). [Patients' rights - medical duties (II). An analysis of the patients' rights law by physicians for physicians].. PubMed. 67(3). 123–5. 1 indexed citations
2.
Evidente, Virgilio Gerald H., Daniel Truong, Joseph Jankovic, et al.. (2014). IncobotulinumtoxinA (Xeomin®) injected for blepharospasm or cervical dystonia according to patient needs is well tolerated. Journal of the Neurological Sciences. 346(1-2). 116–120. 34 indexed citations
3.
Evidente, Virgilio Gerald H., Hubert H. Fernandez, Mark S. LeDoux, et al.. (2013). A randomized, double-blind study of repeated incobotulinumtoxinA (Xeomin®) in cervical dystonia. Journal of Neural Transmission. 120(12). 1699–1707. 49 indexed citations
4.
Kaňovský, Petr, Jarosław Sławek, Zoltán Dénes, et al.. (2011). Efficacy and safety of treatment with Incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity. Journal of Rehabilitation Medicine. 43(6). 486–492. 75 indexed citations
5.
Jankovic, Joseph, Cynthia Comella, Angelika Hanschmann, & Susanne Grafe. (2011). Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial. Movement Disorders. 26(8). 1521–1528. 63 indexed citations
6.
Comella, Cynthia, Joseph Jankovic, Daniel Truong, Angelika Hanschmann, & Susanne Grafe. (2011). Efficacy and safety of incobotulinumtoxinA (NT 201, XEOMIN®, botulinum neurotoxin type A, without accessory proteins) in patients with cervical dystonia. Journal of the Neurological Sciences. 308(1-2). 103–109. 112 indexed citations
7.
Evidente, Virgilio Gerald H., Allison Brashear, Cynthia Comella, et al.. (2011). Poster 131 IncobotulinumtoxinA (XEOMIN; botulinum neurotoxin type A, free from accessory proteins): Flexibility of Dosing and Injection Intervals in Cervical Dystonia. PM&R. 3(10S1). 2 indexed citations
8.
Grafe, Susanne, Cynthia Comella, Angelika Hanschmann, Joseph Jankovic, & Daniel Truong. (2010). Poster 49: Efficacy and Safety of NT 201 (Botulinum Neurotoxin Free From Complexing Proteins) in Cervical Dystonia. PM&R. 2(9S). 2 indexed citations
9.
Kaňovský, Petr, Jarosław Sławek, Zoltán Dénes, et al.. (2009). Efficacy and Safety of Botulinum Neurotoxin NT 201 in Poststroke Upper Limb Spasticity. Clinical Neuropharmacology. 32(5). 259–265. 93 indexed citations
10.
Jankovic, Joseph, Cynthia Comella, Angelika Hanschmann, & Susanne Grafe. (2009). FP50-TH-05 Efficacy and safety of NT 201 (Xeomin®, botulinum neurotoxin type A free from complexing proteins) for the treatment of blepharospasm: results of a double-blind, placebo-controlled, randomized, multi-center trial. Journal of the Neurological Sciences. 285. S137–S138. 1 indexed citations
11.
Grafe, Susanne, Cynthia Comella, Joseph Jankovic, Daniel Truong, & Angelika Hanschmann. (2009). FP50-TH-06 Efficacy and safety of NT 201 (Xeomin®, botulinum neurotoxin free from complexing proteins) in cervical dystonia. Journal of the Neurological Sciences. 285. S138–S138. 1 indexed citations
12.
Kaňovský, Petr, et al.. (2009). FP12-MO-03 NT 201, botulinum neurotoxin free from complexing proteins, Xeomin©) provided sustained efficacy and was safe in spasticity: 89 weeks long-term data. Journal of the Neurological Sciences. 285. S75–S76. 2 indexed citations
13.
Jankovic, Joseph, et al.. (2008). Relationship between various clinical outcome assessments in patients with blepharospasm. Movement Disorders. 24(3). 407–413. 116 indexed citations
14.
Wohlfarth, Kai, Christian Müller, Irena Sassin, Georg Comes, & Susanne Grafe. (2007). Neurophysiological Double-Blind Trial of a Botulinum Neurotoxin Type A Free of Complexing Proteins. Clinical Neuropharmacology. 30(2). 86–94. 56 indexed citations
15.
Kircheis, G., Wolfgang E. Fleig, Roman Görtelmeyer, Susanne Grafe, & Dieter Häussinger. (2007). Assessment of low-grade hepatic encephalopathy: A critical analysis. Journal of Hepatology. 47(5). 642–650. 43 indexed citations
16.
Jost, Wolfgang H., et al.. (2007). Botulinum Neurotoxin Type A Free of Complexing Proteins (XEOMIN??) in Focal Dystonia. Drugs. 67(5). 669–683. 89 indexed citations
17.
Roggenkämper, P., et al.. (2005). Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm. Journal of Neural Transmission. 113(3). 303–312. 185 indexed citations
18.
Benecke, R., et al.. (2005). A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia. Neurology. 64(11). 1949–1951. 202 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Benjamin Zakine Breakdown of academic impact, for papers by Fereshte Adib Saberi Breakdown of academic impact, for papers by Angelika Hanschmann Breakdown of academic impact, for papers by Ivana Basta Breakdown of academic impact, for papers by A. Richardson Breakdown of academic impact, for papers by Sara Samadzadeh Breakdown of academic impact, for papers by N. Heye Breakdown of academic impact, for papers by A Joffroy Breakdown of academic impact, for papers by Christoph Schmitz Breakdown of academic impact, for papers by Madlen Loebel
Rankless by CCL
2026